The aim of this study was to evaluate the bitterness of amlodipine besylate (AML) combined with other five antihypertensive drugs: alacepril, benazepril, hydrochlorothiazide, telmisartan (TEL) and valsartan (VAL), which have possibility of usage as a fixed‐dose combination (FDC) drugs.

Valsartan effectively masks the bitterness of amlodipine besylate in fixed-dose combination with other antihypertensive drugs, making it a promising strategy for taste masking in fixed-dose combination drugs.

Journal of Pharmacy and Pharmacology

A new strategy for taste masking on bitter drug by other combined drug in fixed‐dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan

Paper

A new strategy for taste masking on bitter drug by other combined drug in fixed‐dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan

References

Citations